Related Experiment Videos
[Future of immunologic therapy of bronchogenic carcinoma]
G Saviano1, G Borrelli, V Cerbone
1VIII Divisione di Pneumotisiologia, U.S.L. 41, Ospedale V. Monaldi, Napoli.
Archivio Monaldi Per Le Malattie Del Torace
|September 1, 1990
Abstract:
The AA. report their experience as to the treatment applied to patients suffering from unremovable bronchial cancers. They can therefore stress the results obtained by chemotherapeutic treatment associated to thymopentin as well as interferon-thymopentin treatment. Elderly patients were subjected to interferon-thymopentin therapy, which helped in improving their life standard and survival.